Drug firm Suven Life Sciences today reported 47.71 per cent dip in standalone net profit to Rs 16.94 crore for the fourth quarter ended March 31, 2015.
The company had posted net profit of Rs 32.40 crore for the January-March period of the previous fiscal, 2013-14, Suven Life Sciences said in a filing to BSE.
Standalone net sales of the company stood at Rs 110.66 crore for the fourth quarter of last fiscal as against Rs 130.80 crore in the year-ago period.
The company posted a standalone net profit of Rs 108.75 crore for the financial year ended March 31, 2015 as against Rs 144.15 crore in 2013-14.
Standalone net sales of the company stood at Rs 520.85 crore for 2014-15, as against Rs 510.31 crore for the previous fiscal.
In a separate filing to the BSE, Suven Life Sciences said it's board has recommended a dividend of Re 0.60 per share fro the financial year 2014-15.
Shares of Suven Life Sciences were trading at Rs 280 per scrip, down 6.62 per cent, on the BSE.
